Health Grants

National Institutes of Health · Up to $200K

NIH (NCI) R21 funding for secondary analysis and integration of existing datasets to study cancer risk and related outcomes; clinical trials are not allowed under this notice. Intended for research institutions and investigators, including minority-serving and tribal colleges. The listed maximum is about $200,000. This is institution-based research funding using existing data, not suited to individuals or general nonprofits.

National Institutes of Health · Up to $350K

NIH (NCCIH) R01 funding for multi-site feasibility clinical trials of mind-and-body interventions to prepare for a later full-scale efficacy trial. Intended for research institutions able to coordinate across multiple sites; foreign organizations are not eligible (foreign components allowed). The listed maximum is about $350,000. Sufficient preliminary data from prior single-site work is required, making this narrowly scoped research funding.

National Institutes of Health · Amount varies

This NIH R34 grant funds feasibility trials of mind-and-body complementary health interventions for NCCIH-designated high-priority conditions, generating data needed to plan a subsequent full-scale efficacy or effectiveness trial. Applicants are encouraged to consult NCCIH staff before applying, and it's aimed at eligible U.S. research institutions. The deadline is November 17, 2026.

National Institutes of Health · Amount varies

This NIH R01 grant funds research applications studying the ethical, legal, and social implications of human genetics and genomics, using empirical, conceptual, legal, or normative methods. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP); those without one won't be reviewed. It's aimed at eligible U.S. and territorial research institutions, and the deadline is November 18, 2026.

National Institutes of Health · Amount varies

This NIH R21 grant funds exploratory and developmental research into the ethical, legal, and social implications of human genetics and genomics, particularly studies examining new or emerging genomic technologies. It's open to eligible U.S. and territorial research institutions using empirical, conceptual, legal, or normative methods. The deadline is November 18, 2026.

National Institutes of Health · Amount varies

NIH cooperative-agreement (UG3/UH3) funding for bundled early-stage (Phase 1 to 2a) clinical drug development of novel therapeutics for Alzheimer's disease and related dementias, focused on non-amyloid/non-tau mechanisms. Intended for research institutions able to run gated, milestone-driven clinical trials. No award amount is stated. This is highly specialized clinical research funding, not suited to individuals or general nonprofits.

National Institutes of Health · Amount varies

NIH (NINDS) cooperative-agreement funding (UG3/UH3) for multi-site clinical trials and biomarker studies on stroke prevention, treatment, and recovery, conducted within the NIH StrokeNet infrastructure. Suited to research institutions that will collaborate inside StrokeNet; foreign organizations are not eligible. No specific amount is given. Work must be carried out within StrokeNet and is selected competitively, making this narrow research-only funding.

National Institutes of Health · Up to $375K

NIH HEAL Initiative R15 funding for basic or mechanistic pain research at institutions eligible for the R15 (Research Enhancement) mechanism, which targets schools and components that have not been major NIH recipients. Aimed at engaging undergraduate, graduate, and health-professional trainees in the research; foreign organizations are not eligible. The listed maximum is about $375,000. R15 eligibility rules restrict which institutions can apply, so eligibility is narrow.

National Institutes of Health · Amount varies

NIH mechanism allowing existing award recipients to apply for revision (supplemental) funding to expand a current NIH grant or cooperative agreement, only in response to a specific Notice of Special Interest. Restricted to organizations that already hold an active NIH single-project award. No award amount is specified. Because applicants must already be NIH grantees and respond to a matching NOSI, eligibility is narrow and not open to new applicants.

Centers for Disease Control and Prevention - ERA · $3M–$5.8M

CDC/NIOSH cooperative-agreement (U54) funding to establish a National Center for Construction Safety and Health Research and Translation. The notice does not list specific applicant types (eligibility marked N/A), but the scope describes a multidisciplinary center led by a qualified research organization, with collaborations from academic and nonprofit partners expected, so confirm eligibility in the full notice. Awards range from about $3,000,000 up to $5,750,000. This is a large, center-scale award; the listed eligibility detail is limited.

National Institutes of Health · Amount varies

NIH individual postdoctoral fellowship (F32) supporting a named postdoctoral fellow to analyze the ECHO program's longitudinal child-health dataset within the NICHD DASH repository. This is an individual fellowship awarded through a sponsoring US institution; foreign organizations are not eligible and foreign components are not allowed. No award amount is stated. It is restricted to eligible postdoctoral researchers at a US institution, so eligibility is narrow.

National Institutes of Health · Amount varies

This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, for research that does not involve leading an independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, with a required independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R50 award provides salary support for established Research Software Engineers who build and disseminate biomedical software, tools, and algorithms. Eligible applicants include universities and research institutions; foreign (non-U.S.) organizations are not eligible to apply. It is tied to an existing research environment and specialized staff, so it suits research institutions rather than general nonprofits or individuals applying on their own. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH/NHLBI R61/R33 supports investigator-initiated Phase I clinical trials for therapeutics or diagnostics for heart, lung, blood, and sleep disorders, with the first phase funding final pre-trial preparation. A clinical trial is required. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It is aimed at research teams with clinical-trial capacity. No specific award amount is stated.

National Institutes of Health · Up to $375K

This NIH R15 (AREA) award supports small-scale research at undergraduate-focused institutions that receive limited NIH funding, with a required clinical trial. Eligibility is restricted to institutions that award baccalaureate science degrees and have received no more than $6 million/year of NIH support in 4 of the last 7 years; foreign organizations are not eligible to apply. The maximum award is about $375,000. This is narrowly targeted at less-research-intensive degree-granting institutions.

National Institutes of Health · Amount varies

This NIH R01 funds larger-scale research testing and disseminating interventions to improve health in Native American populations, following the same research focus as its companion R34 announcement. Eligible applicants include universities, tribal colleges, minority-serving institutions, and community organizations, with foreign entities restricted. No award amount is specified.

National Institutes of Health · Amount varies

This NIH R34 planning grant supports research on prevention and intervention strategies for fetal alcohol spectrum disorders across the lifespan, intended as a precursor to larger studies. Eligible applicants include universities, research institutions, and tribal and community organizations, and foreign organizations are listed among eligible applicants. It is aimed at research teams preparing for larger FASD studies. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R21 funds development of novel theory and methods for understanding the genetic architecture of complex human traits, using interdisciplinary approaches, simulations, and existing large-scale datasets; no clinical trial is allowed. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It is aimed at research teams with methodological expertise. No specific award amount is stated.

National Institutes of Health · Up to $1.5M

This NIH/NHLBI R33 supports investigator-initiated Phase I clinical trials for therapeutics or diagnostics for heart, lung, blood, and sleep disorders; a clinical trial is required and applicants must be ready to start the trial early. Eligible applicants include universities, research institutions, and tribal and community organizations; foreign organizations are not eligible to apply, though non-U.S. components of U.S. organizations are. The maximum award is about $1.5 million. It requires clinical-trial readiness.